Become a credit card member today!
Vetmedin Solution for Dogs, 1.5mg/50mL
Description
VETMEDIN Solution (pimobendan oral solution) is the only oral solution approved by the FDA to delay the onset of congestive heart failure (CHF) in dogs with Stage B2 preclinical myxomatous mitral valve disease (MMVD), and management of the signs of mild, moderate, or severe CHF in dogs due to clinical MMVD or dilated cardiomyopathy (DCM.2,3,5 Given every 12 hours, its unique dual mode of action reduces the preload and afterload on the heart while improving contractility of the heart muscle.1 Pimobendan, the active ingredient in VETMEDIN, reduces stress on the heart and increases cardiac output without raising oxygen or energy consumption. Increasing age is a risk factor for heart disease and heart failure.4 When used as directed, VETMEDIN is demonstrated to deliver delayed symptoms with preclinical disease, and improved quality of life and survival for dogs in heart failure.2,3,5 Ask your veterinarian if VETMEDIN is right for your dog.
- - The only medication approved by the FDA to delay the onset of CHF in dogs with Stage B2 preclinicalMMVD.2,3,4
- - When used as directed for dogs with heart failure due to MMVD, it isdemonstratedto increase survival time and improve quality of life
- - Available as an oral solution that makes administration easy for dogs that prefer liquid medication and delivers just the right dose they need
- - References: 1.Hggstrm J,BoswoodA, OGrady M, et al. Effect ofpimobendanor benazepril hydrochloride on survival times in dogs with congestive heart failure caused by naturally occurring myxomatous mitral valve disease: the QUEST study. J Vet Intern Med. 2008;22(5):1124-1135. 2. Lombard CW,JnsO,BussadoriCM; for theVetSCOPEStudy. Clinical efficacy ofpimobendanversus benazepril for the treatment ofacquiredatrioventricular valvular disease in dogs. J Am Anim Hosp Assoc. 2006;42(4):249-261. 3.Keene et al ACVIM consensus guidelines for the diagnosis and treatment of myxomatous mitral valve disease in dogs J Vet Intern Med 2019 5.VETMEDIN Solution (pimobendanoral solution)(prescribing information). St. Joseph, MO: Boehringer IngelheimVetmedica, Inc.; 2016. 4.BoswoodA., Hggstrm J., Gordon
Please note that the product information displayed is provided by manufacturers, suppliers and other third parties and is not independently verified by Petco.
Specifications
| SKU | 4718968 |
|---|---|
| Primary Brand | Vetmedin |
| Days to Ship | Ships Next Business Day |
| Personalized Item flag | No |
|---|
| Volume | 50 ML |
|---|
VETMEDIN Solution (pimobendan oral solution) should be administered directly in the mouth (orally) at a total daily dose of 0.23 mg/lb (0.5 mg/kg) body weight. Do not mix into food. The total daily dose should be divided into 2 equal portions administered approximately 12 hours apart (ie., morning and evening). The syringe is calibrated to deliver the appropriate morning or evening dose when drawn to the dog's nearest weight in pounds, each dose should be rounded up to the nearest 1 lb. increment. Do NOT shake the bottle before or after to avoid foaming.
Federal law restricts this drug to use by or on the order of a licensed veterinarian. The safety of VETMEDIN (pimobendan) Chewable Tablets has not been established in dogs with asymptomatic heart disease or in heart failure caused by etiologies other than MMVD or DCM. The safe use of VETMEDIN has not been evaluated in dogs younger than 6 months of age, dogs with congenital heart defects, dogs with diabetes mellitus or other serious metabolic diseases, dogs used for breeding, or pregnant or lactating bitches.
Description
VETMEDIN Solution (pimobendan oral solution) is the only oral solution approved by the FDA to delay the onset of congestive heart failure (CHF) in dogs with Stage B2 preclinical myxomatous mitral valve disease (MMVD), and management of the signs of mild, moderate, or severe CHF in dogs due to clinical MMVD or dilated cardiomyopathy (DCM.2,3,5 Given every 12 hours, its unique dual mode of action reduces the preload and afterload on the heart while improving contractility of the heart muscle.1 Pimobendan, the active ingredient in VETMEDIN, reduces stress on the heart and increases cardiac output without raising oxygen or energy consumption. Increasing age is a risk factor for heart disease and heart failure.4 When used as directed, VETMEDIN is demonstrated to deliver delayed symptoms with preclinical disease, and improved quality of life and survival for dogs in heart failure.2,3,5 Ask your veterinarian if VETMEDIN is right for your dog.
- - The only medication approved by the FDA to delay the onset of CHF in dogs with Stage B2 preclinicalMMVD.2,3,4
- - When used as directed for dogs with heart failure due to MMVD, it isdemonstratedto increase survival time and improve quality of life
- - Available as an oral solution that makes administration easy for dogs that prefer liquid medication and delivers just the right dose they need
- - References: 1.Hggstrm J,BoswoodA, OGrady M, et al. Effect ofpimobendanor benazepril hydrochloride on survival times in dogs with congestive heart failure caused by naturally occurring myxomatous mitral valve disease: the QUEST study. J Vet Intern Med. 2008;22(5):1124-1135. 2. Lombard CW,JnsO,BussadoriCM; for theVetSCOPEStudy. Clinical efficacy ofpimobendanversus benazepril for the treatment ofacquiredatrioventricular valvular disease in dogs. J Am Anim Hosp Assoc. 2006;42(4):249-261. 3.Keene et al ACVIM consensus guidelines for the diagnosis and treatment of myxomatous mitral valve disease in dogs J Vet Intern Med 2019 5.VETMEDIN Solution (pimobendanoral solution)(prescribing information). St. Joseph, MO: Boehringer IngelheimVetmedica, Inc.; 2016. 4.BoswoodA., Hggstrm J., Gordon
Please note that the product information displayed is provided by manufacturers, suppliers and other third parties and is not independently verified by Petco.
Specifications
| SKU | 4718968 |
|---|---|
| Primary Brand | Vetmedin |
| Days to Ship | Ships Next Business Day |
